A set of isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Initial set of 519 isogenic deletions provides 56% genome coverage.
The current Exelixis collection at the Bloomington Stock Center differs from the original described in FBrf0175003 : a significant number were shown not to carry a deletion and have been removed from the collection; a number of stocks have been lost; a number of additional deletions are included that were generated after publication.
100B4;100B8
The 'fused wing' phenotype (partial fusion between L3 and L4 veins) observed in flies expressing smoPKA12.UAS under the control of Scer\GAL4C-765 is strongly enhanced by combination with Df(3R)Exel6219 in heterozygous state, which leads to significantly smaller wing blade and severe vein defects.
Deletion does not exist in stock, see reference for details.